Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in United States and Canada

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).

From the University of British Columbia, Vancouver, Canada (TT); University of California, San Francisco, CA (DH, LF); Behavioral Diabetes Institute, San Diego, CA (WHP); University of California, San Diego, CA (WHP); Eli Lilly and Company, Indianapolis, IN (BR, MP-N); Eli Lilly and Company, Canada (TI); Analysis Group, Inc., Boston, MA (UD).